The success of the dermatology industry in 2022, with approvals for Alopecia Areata and Vitiligo, brings new opportunity for dermatology drug development.
North America's Definitive Microbiome Drug Development Event Dedicated to Moving the Needle Forward on Microbial-Based Drug Development Innovation and Healthcare Industry Adoption.
Following an invite to fly into Parma, Italy to witness first-hand the press launch of the considerable structure that is the Chiesi Group’s new €85 million Biotech Centre
The advancements made in drug development over the last decade have seen the arrival of a number of treatments that offer one-time cures and more effective therapies for conditions in small
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.